Clinical Trial Update: TMC435-TiDP16-C114 - A Study in Healthy Volunteers Investigating the Pharmacokinetic Interaction Between TMC435 and the Antiretroviral Agents TMC278 and Tenofovir [Phase 1]

View source ↗

Summary

Phase 1 study in healthy volunteers evaluating pharmacokinetic interactions between TMC435 and antiretroviral agents TMC278 and tenofovir; the trial has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• TENOFOVIR DISOPROXIL FUMARATE (tenofovir disoproxil fumarate)
• TMC278 (rilpivirine)
• TMC435

Snippet

Sponsor: Tibotec Pharmaceuticals, Ireland | Conditions: Hepatitis C Virus | Phase 1 | Status: COMPLETED